You are here: Industry Insights > cancer

News List

Attenuated Diptheria Toxin Developed by Researchers as Novel Form of Drug Delivery Europeanpharmaceuticalreview
May 07, 2020
A new potential platform for drug delivery has been created by researchers using attentuate diptheria toxin, which can enter cells and escape the endosome.
DelMar Updates Clinical Trial of VAL-083 for Adjuvant Treatment of Brain Tumors americanpharmaceuticalreview
May 07, 2020
DelMar Pharmaceuticals has enrolled 22 patients in the adjuvant arm of the Company's ongoing Phase 2 clinical study investigating adjuvant treatment (pre-temozolomide -- or TMZ -- maintenance therapy) of MGMT-unmethylated glioblastoma multiforme (GBM) ...
AGC Biologics Inks Manufacturing Deal with Faron contractpharma
May 07, 2020
The CDMO will manufacture novel precision cancer immunotherapy treatment Clevegen.
Crescendo links with CRUK to progress cancer therapy pharmatimes
May 06, 2020
Crescendo Biologics and Cancer Research UK have entered into a Clinical Development Partnership to progress one of Crescendo’s novel bispecific Humabody immunotherapies, CB213, into clinical trials targeting cancers of high unmet medical need.
Bayer faces second investor reckoning over glyphosate litigation expresspharma
April 29, 2020
Criticism from investors at this year’s annual shareholders’ meeting – held in a virtual format with gatherings banned due to the coronavirus – will likely be less scathing than it was in 2019.
NICE backs NHS use of Bayer's Vitrakvi via the CDF pharmatimes
April 26, 2020
Bayer's Vitrakvi (larotrectinib) will be available via the NHS in England and Wales to treat a variety of cancers.
Novel cannabinoid formula could be used as a cancer treatment europeanpharmaceuticalreview
April 17, 2020
The developers of the novel formulation, containing the cannabinoids CBDV and CBGA, now intend to test the clinical safety and efficacy of its anti-cancer activity.
TScan and Novartis partner to develop cancer therapies pharmaceutical-technology
April 17, 2020
Biopharmaceutical firm TScan Therapeutics has signed an agreement with Novartis to discover and develop therapies for the treatment of cancer.
Zenfold Ventures takes equity stake in Esperer Onco Nutrition expresspharma
April 16, 2020
Over the next two years, Esperer Onco Nutrition plans to have more technical collaborations with international technical authorities to expand its research and product portfolio.
Tango Therapeutics banks $60M to push synthetic lethality drug fiercebiotech
April 13, 2020
Many cancer patients have benefited from targeted therapies that switch off cancer-driving oncogenes, but others, whose disease is driven by the loss of tumor-suppressing genes.